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Cytochrome P450s are a superfamily of metalloenzymes that are responsible for 
the monooxygenation of their hydrophobic substrates. P450’s retain the same 
general structural scaffold, however are able to bind promiscuously to substrates 
with distinct physico-chemical properties. It is believed that they possess 
considerable flexibility in the substrate binding regions as well as their active site 
to accomplish the diverse binding and catalytic chemistry with high regio- and 
stereo-specificity. In order to investigate the conformational dynamics inherent in 
these enzymes, especially in context of binding different ligands, we carried out 
amide proton exchange studies via NMR spectroscopy on a model P450 system 
of cytochrome P450cam (CYP101). These studies were performed in both 
camphor-bound and substrate-free forms of CYP101 and provide information on 
the motional properties of residues on slow timescales. Comparison of the 
exchange rates obtained from these studies for the two forms show that overall 
the substrate-free form is more dynamic than the camphor-bound form on the 
millisecond-second timescale due to its faster exchange rates, with regions being 
part of the substrate access site and active site in particular showing the largest 
differences in exchange rates. This study is the first of its kind looking at the 
residue-level changes in conformational dynamics upon ligand binding in a P450 
and identifies specific regions where slow dynamic changes occur. Results from 
these studies help provide mechanistic insights into the process of differential 
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DYNAMIC NATURE of ENZYMES 
 
1.1 Enzyme Promiscuity Strategies 
 
Enzymes are complex proteins that undertake specific catalytic tasks, allowing 
substrates to be catalyzed into product. Enzymes can be highly specific, catalyzing one 
or two substrates, or they can catalyze many substrates. The question of how this is 
possible has always been prevalent, and there are a few proposed hypotheses. One 
details how the overall structure and function of members of protein super-families 
catalyze completely different reactions. A prominent example of this is the α/β hydrolase 
family (1). While maintaining a catalytic triad, the different enzymes of this family can 
catalyze the breakage of carbon-carbon bonds, the hydrolysis of carbon-halogen bonds 
and ester bonds. In their work, the researchers note that there is less than 10% 
sequence homology between the members of the super-families, but their overall 
structure remains the essentially the same.  This indicates that an enzyme that can 
perform a different function (or multiple functions) can more quickly diverge from it’s 
ancestors and become more favored evolutionarily (1).  There are several examples of 
such catalytic promiscuity, where one isoform of an enzyme can perform different 
chemical reactions on different substrates, such as carbonic anhydrase III, which has 
been known to perform hydration of CO2 and hydrolysis of carbon esters and 
phosphoesters (1). However, there are also enzymes that can perform one chemical 
reaction on various different types of substrates. How these varying catalytic functions 
are accomplished is an intriguing question. 
 
A hypothesis that is rapidly emerging and being widely accepted as to how these 
enzymes can be promiscuous is that these enzymes are believed to have high 
conformational plasticity.  This is similar to the plasticity exhibited by intrinsically 
disordered proteins (IDPs) (2). The hypothesis on the promiscuity of IDPs is that their 
flexibility can change when bound to different binding partners, but is not necessarily a 
reflection of the ligand binding (3). A likely mechanism by which this promiscuity is 
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accomplished is that of conformational selection, or equilibrium dynamics. The 
conformational selection model is widely believed to operate in promiscuous substrate 
binding by enzymes, which typically are highly mobile entities. In this model, the 
enzyme does not have one structure, which fits exactly around the substrate, as per the 
lock and key model; neither does it have only one conformation, where it may slightly 
change it’s shape to accommodate a substrate, as described by the induced fit model. 
Conformational selection occurs when the enzyme itself samples multiple conformations 
at once in solution, and the substrate favorably binds to one of those. The equilibrium of 
the conformations shifts, and the most favorable conformations are the ones that 
catalyze with the greatest efficiency.  
 
Unlike IDPs, enzymes do not necessarily have to exhibit flexibility over the 
entirety of the protein. The equilibrium dynamics can be localized only to the binding or 
active sites. Parigi and colleagues observe that mutations of the binding site of the IDP, 
α-synuclein, do not affect the relaxation rates of the binding site, or any other parts of 
the protein, which is distinct from the equilibrium dynamics mechanism (3). This 
indicates that any localized perturbations are diffused over the entire protein and may 
not result in selection of certain conformations with distinct dynamic properties. It should 
be noted however that their relaxation measurements were done in the pico-
nanosecond timescale, so it is possible that this protein is differentially dynamic on other 
timescales. Another difference between IDPs and enzymes that exhibit equilibrium 
dynamics, is that there is no stable, favored conformation for catalysis (3). This implies 
that these enzymes have natural high plasticity and this is how they accommodate 
multiple substrates, due to the fact that the catalytic efficiency is not greatly affected.  
The flexibility, or dynamics of the protein, allows it to bind multiple ligands. Aharoni et al 
observe that the substrate binding region of α-lytic protease has various loops, which 
increase in flexibility upon mutation. The mutation increases the promiscuous binding 
behavior of the enzyme by 105, while only decreasing the catalytic efficiency by half (4). 
An important component of the conformational selection model is that the enzyme must 
have structural flexibility (4, 5). 
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1.2 Conformational Plasticity of Cytochrome P450’s 
 
A prominent class of enzymes that exhibit great conformational plasticity are the 
ones belonging to the family of cytochrome P450s. Cytochrome P450s are promiscuous 
heme-containing monoxygenases, present in all kingdoms of life (6) that aid in 
biosynthesis and the metabolism of many xenobiotics, including drugs in humans. A 
typical reaction carried out by these enzymes is the monooxygenation of their 
substrates, in order to make them more soluble (Eq 1).  
 
RH+ O! + 2  e! + 2  H!   → ROH+   H!O                         Eq.1 
 
This reaction requires 2 electrons and 2 protons, which are supplied by 
NAD(P)H. The electrons are carried by an electron transfer protein, which varies 
depending on which P450 it is. Another interesting thing about the electrons is that they 
are transferred one at a time. The catalytic cycle (Figure 1) is as follows: The heme iron 
is in its +3 oxidation state when the substrate binds. The first electron is transferred 
following this, converting the iron to +2 oxidation state. Molecular oxygen then binds to 
the iron and the first electron is transferred from Fe+2 to oxygen, creating a radical. At 
this point, the second electron is transferred to the system, creating an iron-oxene. 
Next, two protons come and sequester an oxygen atom, forming H2O which then 
leaves. This allows the oxygen and iron to form a complex. Rearrangement occurs, 
which makes the substrate susceptible to hydroxylation, forming the product, which then 
allows the hydroxylated product to exit the active site. 
 
Monooxygenation reactions such as those carried out by P450s are notoriously 
difficult to carry out without an enzyme due to the high amount of energy required for 
activating the C-H bond for oxygen insertion and would require heating the reactants to 
very high temperatures to facilitate the reaction. Its ability to make such a reaction 
possible under ambient conditions has earned this enzyme the name, “Nature’s 






Figure 1: Catalytic Cycle of Cytochrome P450. The substrate RH enters and 
proceeds to be hydroxylated to the product ROH by a series of steps, including the 









A large percentage of pharmaceutical drugs (>90%) are metabolized by several 
isoforms of the P450 enzyme in humans using the above catalytic cycle. Although these 
enzymes can metabolize all of these drugs with very distinct physico-chemical 
properties, the efficiency of catalysis is not always optimal, leading to byproducts and 
drug toxicity. For example, the well-known non-steroid anti inflammatory drug (NSAID) 
acetaminophen, known by trade name Tylenol, is a substrate of CYP3A4. One of the 
intermediates that it produces, known as NAPQI, is a toxin known for interactions with 
other proteins, hence the high toxicity of this drug. P450’s catalyze a hydroxylation and 
a rearrangement of acetaminophen, which is one more step than the usual 
hydroxylation (9). The reason for this may be that acetaminophen is not an ideal 
substrate for P450, which is why it can have toxic intermediates, and therefore toxic 
side effects. If the precise recognition and binding of various drugs was known, 
pharmaceutical companies could avoid this to a large extent. Members of the P450 
superfamily, whether bacterial or human (Figure 2), retain remarkably similar structural 
architecture or fold, while adapting to varying needs of substrate recognition and the 
regio- and stereo- chemistry of the reactions catalyzed using a dynamic rearrangement 
of their secondary structural features depending on the substrate, cofactor or oxidation 
state. Thus, one of the main focuses recently, apart from elucidation of P450 structural 
factors, is the investigation of how this conformational flexibility of cytochrome P450 
enzymes allows for modulating of protein-substrate interactions to accommodate 
substrates of differing physico-chemical properties as well as product specificity. For 
this reason, studying the dynamics of P450s will help in the fundamental understanding 
of its substrate promiscuity. 
 
The extent of flexibility of these enzymes became apparent with the discovery by 
Scott and coworkers that a soluble version of cytochrome 2B4 from rabbit exhibits a 15 
Å separation of the components of the substrate binding regions as part of a large open 
active site, making it capable of large displacements to accommodate substrates of 













Figure 2: Structural Fold Similarities of cytochrome P450s. The structures of a 
bacterial P450, CYP101 (left panel) and a human P450 isoform, CYP2C9 (right panel) 
are shown. Although some differences exist, the general structural fold is maintained, 











active site is marked by a cleft of 10 Å or less in any P450 structure solved previously 
(10, 11). The substrate access channels, present in membrane bound P450’s, also 
revealed openings of only 2-3 Å, which does not provide enough space to allow the 
substrate to pass through the channel (11-13). Yet, somehow they do. This allowed for 
the notion to develop that these enzymes have considerable flexibility, which could be 
exploited to bind diverse substrates, providing impetus for further dynamic studies of 
P450s by both computational and experimental methods. 
 
Crystal structures of several P450s, both bacterial and from other higher 
organisms, reveal considerable variability in regions around the active sites of these 
enzymes. While the active site comprising the heme center is buried inside the protein, 
the substrates access the active site via an access channel comprised of secondary 
structure elements collectively known as the substrate recognition sites or SRS (Figure 
3). The SRS typically include several helices such as the B’, F, G and I helices as well 
as some beta-sheets such as the β 1, 3 and 5 sheets (6, 11, 14). Other P450’s 
generally exhibit the same SRS, although in the human P450s there are additional 
identified flexible regions (11, 15). Also, the length of the flexible regions varies between 
the prokaryotic and eukaryotic P450s, with mammalian P450s having longer F-G and B-
C loops, leading to generally increased flexibility in these regions for the mammalian 
ones and with better adaptability to accommodate substrates of increasing size due to 
larger binding pockets. Essentially, there have been many studies that have determined 
that multiple loops and their adjoining helices are a part of the SRS machinery that 
allows P450s to be so dynamic (15). However, no matter the components, the 
placement of the SRS is generally in the same location. In spite of this knowledge, it is 
not entirely clear which specific residues within the various P450s undergo the greatest 
rate of dynamic change to effect substrate binding, and how that change is affecting the 








Figure 3: Substrate Recognitions Sites of CYP101. The various substrate recognition 
sites (SRS’s) are structurally highlighted in cyan, and are highly dynamic regions of the 
protein, which facilitate binding of a multitude of ligands to CYP101. SRS’s are 
numbered, with each numbered SRS containing the structural element as well as 









Computational studies by Wade and coworkers have attempted to identify pathways by 
which substrates may enter into and products may exit from the active site using 
molecular dynamics simulations on several P450s (13). They found existence of many 
access channels with some common ones among all P450s that involved several 
flexible elements of the SRS such as the F-G, B-C helices and loops. These studies 
again indicate the dynamic nature of the access/egress paths and provide functional 
rationalization for the structural variability of these regions in the crystal structures 
solved for the different P450s so far. The dynamic behavior of these regions also makes 
it difficult to use computational modeling and dock compounds into the SRS or active 
site of a P450 during the process of computational drug design.   
 
The flexible nature of these enzymes have to be taken into account during the 
docking process and without sufficient knowledge of the conformational selection a 
P450 can undergo, it is difficult to simulate the docking process and know which 
conformation a compound is most likely to bind to, because it is unknown. The 
mechanism by which these conformations are selected is unknown, and how they 
switch from one to the other is also unknown. Therefore, experimental approaches to 
augment the dynamic information during the docking process can help with more 
efficient discovery of drug-like molecules and prevent unwanted levels of toxicity due to 
incomplete catalysis or weak binding when applied in practice. Experimental 
approaches incorporating NMR, EPR, IR and mass spectrometry are increasingly being 
used (15-17) to characterize the dynamic properties of P450 enzymes, however 
systematic studies involving several ligands and how the dynamic properties of these 
enzymes change in response to different ligands have not been carried out yet, which 
are essential to understand the structural-dynamic relationships in these enzymes. 
Discovering how the dynamics of various P450 regions are key in ligand recognition and 
the specific mechanism by which they accomplish differential ligand binding will be a 





CHAPTER II  
INVESTIGATION OF DYNAMICS OF A MODEL P450 ENZYME, 
CYTOCHROME 450CAM (CYP101) 
 
2.1 Cytochrome P450cam as a Model System 
 
Given the conformational plasticity of cytochrome P450s and variability in the 
SRS, assessing the dynamic and mechanistic factors that give rise to conformational 
selection within the individual P450s as a function of ligand (substrate or inhibitor) 
binding is an important goal among the researchers in the P450 area. A dynamic 
comparison between distinct ligand bound states could provide further evidence that 
conformational selection may be a ubiquitous mechanism within the P450 superfamily. 
The first cytochrome P450 to be structurally and mechanistically characterized in detail 
was cytochrome P450cam (CYP101) from the bacterium, Pseudomonas putida (18). 
CYP101 is a hydroxylase for its natural substrate camphor, which the bacterium uses as 
carbon and energy source. It utilizes two electrons to catalyze its reaction that are 
transferred to it by its redox partner, putidaredoxin (Pdx), a [2Fe-2S] ferredoxin from the 
same organism. Since its structural characterization by X-ray crystallography, it has 
served as model system for further mechanistic investigation, such as elucidation of 
catalytic mechanism of P450s, ligand entry and binding to active site as well as redox 
partner binding and electron transfer. CYP101 is thus a well-studied cytochrome and 
there is much information available on it. It is soluble and the methods of growth and 
expression have been well optimized. It is also becoming increasingly evident that it is a 
fairly promiscuous enzyme with ability to bind to many ligands (vide infra) and exhibiting 
conformational flexibility rivaling other P450 enzymes, due to large structural differences 
(~ 10 Å) between its camphor-bound (Figure 4) and its wide open substrate-free 
conformation (Figure 5) (19). Therefore, it forms an ideal system to initiate dynamic 
studies since the knowledge gained by studying this model system will provide insights 
into how other P450s are also likely to utilize their flexibility in effecting ligand binding 







Figure 4: X-ray crystal structure of camphor Bound CYP101. SRS is highlighted in 
gold. As shown, the various SRS elements are enclosed over the active site, allowing 





Figure 5: X-ray crystal structure of substrate-free CYP101. The various SRS 
elements (shown in gold) have moved away from the active site, taking on a more open 










CYP101 is roughly triangular in shape with the heme active site embedded deep 
inside the protein across from the I helix (Figure 4). The substrate camphor accesses 
the active site via a water-filled access channel lined by the various SRS elements such 
as the B’, F and G helices, β3 and β5 sheets as well as the B-C and F-G loops (Figure 
3). Upon entry, camphor is anchored in the active site by hydrogen bonding to side-
chain of Tyr 96 and hydrophobic interactions with the surrounding aromatic and aliphatic 
residues in the active site pocket (Figure 6). The occupancy of camphor in the active 
site displaces the water coordinating the iron at the 6th coordination site, converting the 
substrate-free form of CYP101 to the substrate-bound form. This type of conversion 
upon substrate binding is common to all P450s with their respective substrates. 
Inhibitors of CYP101 enter and bind via similar mechanism, although they may be 
directly coordinated to the heme at the 6th coordination site unlike camphor, which sits in 
close proximity to this site. The 6th site in the camphor-bound form is then coordinated 
with oxygen, necessary for the hydroxylation reaction, which distinguishes the 
catalytically competent substrate binding form from the inhibitor binding form (Figure 7). 
 
While it is generally accepted that the SRS facilitate binding of various ligands via 
a dynamic mechanism, it is not clear how dynamically different the various SRS 
elements are in the presence of different ligands. It is unknown which specific residues 
undergo the greatest rate of dynamic change, and how their changes affect the overall 
dynamics of the various SRS elements. Also, can we discover in which timescale these 
residues are dynamic and what mechanism controls their motions to allow binding of 
multiple ligands? Detailed experimental investigations on these questions have not 
been carried out. If the protein dynamics of CYP101 can be investigated in absence and 
presence of various ligands, then it would be interesting to know if the conformational 
selection model is used in CYP101 and generally as a mechanism for all of P450 









Figure 6: Active Site structure of Camphor-Bound CYP101. The coordination of the 
5th heme site is shown with the thiolate ligand formed by cysteine 357 (behind the heme 
plane) which causes a slight puckering of the heme. The substrate camphor occupies 
the region near the 6th coordination site. Tyrosine 96 forms a hydrogen bond with 











Figure 7: Active site structure of Nicotine-Bound CYP101. The coordination of 
thiolate ligand, Cys357 to the 5th coordination site is shown. A coordination bond is 
formed between nicotine and the heme iron at the 6th coordination site, removing the 
puckering of the heme plane. Tyr96 side-chain also hydrogen bonds to another 
















2.2 Methods for Studying Protein Dynamics 
  
Proteins exist as an ensemble of conformations that are perpetually switching, 
rather than a static entity. All structures, whether determined by crystallography, NMR 
or neuron scattering, represent an average of all the conformations a protein can adopt. 
Proteins use dynamics to facilitate their function. Here, dynamics is defined in the words 
of Henzler-Wildman and Kern as “any time dependent change in atomic 
coordinates”(21). There are equilibrium and non-equilibrium dynamic effects, but those 
at equilibrium are the most relevant to protein function as a result of dynamics.  
 
Dynamics is defined as a time dependent reversible process, and different types 
of motions occur at different timescales. Very fast motions include bond vibration, which 
occurs at the femtosecond timescale. Bond rotations and side chain rotamerization 
occur 10-100 fold slower, at the pico to nanosecond timescale. Loop motions span the 
nano to microsecond timescales. The millisecond and longer timescales include all 
other large domain motions, including helical shifts and overall protein breathing (Figure 
8). All of these timescales can be studied using different techniques, and there are 
optimal techniques for each timescale (21). Molecular dynamics simulations are 
appropriate for the faster timescales, due to the optimization of parameters and 
providing accurate atomic level description of experimental data. Slower timescale data 
produced by MD is less accurate when compared to experimental methods. MD 
simulations have been used with experimental techniques such as neutron scattering to 
allow visualization of protein dynamic motions on a multitude of timescales, from 
femtoseconds to microseconds, by selection of trajectories that best fit experimental 
neutron scattering measurements on these different timescales (22). Although this 
requires considerable amounts of protein samples to obtain good quality neutron 
scattering data, in favorable cases neutron scattering methods can be used to contrast 
amplitude of dynamic motions between various forms of the protein, such as complexed 




Forster resonance energy transfer (FRET) is another popular technique used to 
study protein dynamics. It utilizes two energy transferring fluorophores of differing 
wavelengths of light. If the two tags come in contact with one another, the emitted 
photon is of a certain energy, the spectrum of which can be interpreted both in structural 
and dynamic terms (24). FRET is utilized to determine nano to microsecond dynamics, 
however does not give high-resolution atomic-level dynamic information (24). Also, 
since FRET requires the addition of the fluorophore tags on the protein, the protein may 
not be folded appropriately, depending on the placement and size of the tags. The 
dynamics may also be affected by the placement of the tags.  
 
Another technique to study protein dynamics is X-ray crystallography, which has 
the potential to provide information on distinctive dynamic motions at the nanosecond 
timescale by interpretation of electron density maps as shown in a recent study by 
Fenwick and colleagues on the enzyme dihydrofolate reductase (25). X-ray 
crystallography however requires the formation of crystals, which may not necessarily 
reflect the natural environment of the protein. In order to form the crystals, proteins must 
pack in a certain way, which may trap the protein in a particular conformation or freeze 
out a subset of motions observed in solution. Screening techniques for crystal formation 
also requires a large amount of protein. In spite of these inherent limitations, newer 
methods in X-ray crystallography such as Laue diffraction methods or femtosecond 
serial resolution crystallography allow atomic-level resolution of dynamic events by 
taking snapshots of the proteins in crystals as they perform their function (26). However, 
these techniques suffer from technical limitations in terms of the kind of systems they 
can be applied to obtain dynamic information. 
 
NMR spectroscopy is one of the more versatile spectroscopic techniques to 
study protein dynamics, as it is able to probe picosecond to minute timescales. NMR is 
also non destructive to the sample and requires relatively low concentrations and 
volume of protein. There are different NMR methods to probe time-dependent 












Figure 8: Timescales of different protein motions. Dynamics is a time dependent 























Nuclear spin relaxation rates T1 and T2 can be used in a site-specific manner to probe 
motions in the ps-ns timescale across the protein such as bond vibrations, loop motions, 
sidechain rotations and backbone motions (27). Lineshape analysis of exchange-
broadened resonances and more recently CPMG relaxation dispersion methods have 
been used to quantify exchange processes in the us-ms timeframe such as secondary 
structure reorientations, slower loop motions and large-scale domain movements (28, 
29). Dynamic processes on the ms-min timescale can be detected by monitoring NMR 
signal intensities as a function of time that give information about slower motions 
occurring in dynamic events such as protein folding, conformational disorder and overall 
protein breathing motions that may affect binding and catalytic rates. A common way of 
measuring these types of dynamic behavior is to use hydrogen-deuterium exchange 
(HDX), whereby the exchange of hydrogen atoms between protein and the solvent is 
monitored over a period of time. The HDX technique can be used in conjunction with 
either NMR or mass spectrometry, and has been used for many years to observe 
protein folding and dynamics. One of the first measures of protein dynamics was on the 
CD2 domain of immunoglobulin, which determined that the domain has an intermediate 
which forms after global opening, which has highly protected amides, while the native 
state has non protected amides, which is relevant for the function of this domain (30). 
Recently, HDX has been used to determine the dynamics of membrane proteins using 
solid state NMR (30). In the early days of matrix assisted laser desorption/ionization 
time of flight (MALDI-TOF) mass spectrometry  (MS), Mandell and coworkers used the 
catalytic domain of PKA in order to determine how much the instrument could 
distinguish between fragments, and deuterated and hydrogenated samples (31). After 
this time, amide exchange has been a prominent tool in the determination of slow 
protein dynamics by mass spectrometry. 
 
 In HDX NMR, typically the exchange of backbone amide protons with deuterium 
is monitored after being placed in a completely deuterated solvent such as D2O. Since 
deuterium is not detectable in the 1H-15N HSQC experiment, the exchange process can 
be monitored as a drop in signal intensity in the HSQC spectrum due to loss of protons. 
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The protons exchange differentially based on their relative exposure to the solvent 
which depends on the “breathing” motions of the protein, dictated by the equilibrium 
between the open and closed states of the protein. As such, this type of dynamic motion 
can give information on the relative accessibility of different regions in the protein to the 
solvent and is indicative of the nature of conformational dynamics i.e. fast or slow 
between various forms of the protein. The comparative nature of the HDX data gives a 
good starting point to characterize the global dynamic properties of proteins and see 
where more quantitative site-specific dynamic studies on other timescales can be 
focused in the future. 
 
2.3 Conformational Dynamics of CYP101 
 
 The X-ray crystal structures of CYP101 have been solved in both substrate-free 
and various ligand-bound forms (19). Comparison of the structures reveals that 
substrate-free CYP101 samples a distinct open conformation marked by retraction of 
the F and G helices and disordering of the B’ helix (Figure 5), while the camphor-bound 
form exhibits a closed conformation with the same elements highly ordered due to 
ligand association (Figure 4). The open conformation is similar to those seen in the 
structures of CYP101 with tethered substrates (19), suggesting that CYP101 is 
dynamically capable of undergoing substantial structural changes and visit different 
conformations sampled by substrate-bound forms, indicative of a conformational 
selection model operating in ligand binding. Subsequent double electron-electron 
resonance (DEER) experiments also show existence of this open conformation in 
solution which converts to a closed conformation upon binding camphor, similar to that 
observed in the crystal structures (32). Accelerated MD studies on substrate-free 
CYP101 further reveal existence of a cluster of partially open conformation in addition to 
the open conformation observed in the crystal structures, suggesting that CYP101 is 




Another experimental study to investigate conformational dynamics of CYP101 
was performed by the Ortiz de Montellano group, which looked at how exactly a large 
substrate such as ketoconazole, a potent antifungal, is able to bind its target P450s (34, 
35). Ketoconazole was designed as a target for human CYP3A4, however is able to 
bind to bacterial P450s such as CYP101. In performing the mutation L244A, they found 
interesting implications on the binding of inhibitors, where the mutation was able to 
enhance the conformational plasticity of the active site. Even though the mutation 
involved replacing a larger amino acid with a smaller amino acid in the active site, the 
binding of a small inhibitor imidazole showed much lower affinity than the wild-type 
protein, although the binding of larger inhibitors such as ketoconazole was not affected. 
Due to the mutation, the I helix shifts inwards preventing imidazole from taking an 
orientation to bind favorably to the heme, On the other hand, the mutant active site is 
able to conformationally adjust to accommodate larger substrates such as 
ketoconazole, demonstrating the high conformational plasticity of the active site. 
Whether the same conformation is sampled also in the wild-type protein or in the open 
substrate-free conformation remains to be seen, as the crystal structure of CYP101 with 
ketoconazole has not been solved yet.   
 
The conformational plasticity of the P450 active site can also be seen from NMR 
studies on substrate behavior in the active site using paramagnetically-induced spin 
relaxation of water and substrate in CYP102, which indicated dynamic movement of the 
substrate in the active site (36). Similar reorientation of substrate has been observed for 
camphor and a related substrate, norcamphor, in the active site of CYP101 using NMR 
and fluorescence anisotropy measurements (37). In addition, NMR studies on CYP101 
complexation with Pdx showed that binding of Pdx on the proximal side of heme 
perturbed resonances on the distal side, especially in the substrate binding regions, 
which was hypothesized to occur as a result of Pdx-enforced selection of a subset of 
conformations that prevented loss of substrate before catalysis (38). Furthermore, from 
NMR T1/T2 relaxation experiments on oxidized and reduced forms of CYP101, it has 
been found that the oxidized form of the enzyme is more dynamic than the reduced 
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form and analysis of amide exchange rates as well as backbone dynamics of the protein 
from relaxation data indicated that the dynamic differences while delocalized over the 
entire protein were more pronounced in the SRS regions, providing strong evidence that 
CYP101 may sample different subsets of conformations in the oxidized and reduced 
forms (15). 
 
2.4 Preliminary NMR studies on CYP101 in presence of different ligands 
 
The abundance of data from the various crystal structures in ligand-free and 
ligand-bound forms of CYP101 as well as the numerous spectroscopic studies carried 
out on CYP101 in different forms strongly suggests that CYP101 makes use of its 
inherent flexibility in binding ligands of differing physico-chemical properties. However, it 
is not clear from these studies what specific mechanism is utilized by CYP101 to select 
for the appropriate conformation(s) from the multitude of conformations available to it. A 
systematic study investigating the changes in conformational dynamics in the absence 
and presence of different substrates and inhibitors to delineate specific binding 
mechanisms has not been performed so far. We therefore carried out preliminary NMR 
studies using 15N labeled samples of CYP101 in absence and presence of different 
ligands to obtain insights into the type of structural and dynamic differences apparent 
with these binding events, since NMR spectra are sensitive to both these parameters. 
15N-1H HSQC-TROSY spectra of 15N labeled oxidized CYP101 bound to camphor, 
nicotine and ketoconazole were collected in presence of saturating amounts of ligands. 
The resulting spectra were compared with each other and also the 15N-1H HSQC-
TROSY spectrum of ligand-free CYP101 (Figure 9). Comparison of the various spectra 
produced striking observations. Overall, the chemical shifts between the spectra exhibit 
only small changes, so much so that it is possible to relate the peaks in each form on a 
one on one basis for most part. The chemical shifts in the spectra are also well  





Figure 9: Differential dynamics of CYP101 upon binding to different ligands. 
Portions of 2D 1H-15N HSQC-TROSY NMR spectra of 15N-labeled CYP101 are 
compared with and without various ligands. Dynamic differences in terms of linewidths 
and peak characteristics are clearly observed amongst all spectra. The relevant 
affinities for all ligands (KD values) to CYP101 are listed next to each spectrum and the 
structure of each ligand shown as well. 
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However, the spectrum of ligand-free CYP101 exhibited relatively more conformational 
heterogenity for the protein across much of the spectrum as evidenced by excessive 
line-broadening and splitting of single peaks into multiple peaks for several resonances 
in the spectrum. More than 80% of the peaks show line-broadening, with almost 40% of 
the peaks showing presence of multiple peaks. This is in contrast to the spectrum 
observed for the camphor-bound and nicotine-bound forms, which exhibited 
progressively less of these characteristics. The spectrum of nicotine-bound form 
contains peaks with the narrowest linewidths (almost half linewidth relative to the 
substrate-free form). This is observed for almost all the resonances in the spectrum. 
Interestingly, the spectrum of ketoconazole-bound form of CYP101 exhibits 
conformational heterogeneity similar to that of the substrate-free form with almost 80% 
of the peaks affected. This provides direct evidence that the various ligand-bound forms 
of CYP101 are experiencing conformational exchange on different timescales. This 
differential dynamics likely arises from the conformational selection of a different subset 
of conformations of each form of CYP101, in response to the ligand it binds. Such direct 
observation of differential dynamics in presence of various ligands has not been 
observed previously for a P450 by any experimental method. 
 
It is interesting to note that the affinity of each ligand is very similar and within an 
order of magnitude of each other (Figure 9). Ketoconazole binds with the highest 
affinity, followed by camphor and then nicotine with the lowest affinity. Based on the 
affinity differences, it would be expected that the protein should lose most of its 
conformational mobility upon binding to a large ligand such as ketoconazole with such 
high affinity, presumably due to a multitude of potential binding contacts with the active 
site residues of CYP101. It is therefore surprising that the spectrum of ketoconazole-
bound form exhibits similar, if not more, conformational heterogeneity compared to the 
substrate-free form. On the other hand, conformational heterogeneity and mobility 
seems to be lost upon weaker binding to the nicotine ligand, as indicated by the much 
narrower resonances in the nicotine-bound CYP101 spectrum. The binding of the 
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natural substrate camphor exhibits dynamic characteristics intermediate between that of 
ketoconazole and nicotine in line with its intermediate binding affinity.  
 
A likely explanation for this surprising observation may come from the 
thermodynamic aspects of ligand binding, specifically a phenomenon known as entropy- 
enthalpy compensation. Entropy-enthalpy compensation in terms of ligand binding is 
defined as a change in enthalpy (ΔH), which is offset by a change in entropy (ΔS), 
resulting in no significant change to the overall free energy of binding (39). It is plausible 
that there is an additional entropic contribution in the binding of ketoconazole due to the 
increased conformational dynamics in the protein that is not present in the binding of 
nicotine. Crystal structure of CYP101 with nicotine in the active site shows that apart 
from direct ligation with the heme, nicotine makes only a few specific interactions with 
residues in the active site such as hydrogen bonding withTyr96 (20). The residue 
environment around nicotine in the active site is fairly ordered as evidenced by low B-
factors for most of the residues in that region. Thus, binding of nicotine is very likely an 
enthalpically driven event. On the other hand, the increased conformational 
heterogeneity for substrate binding region residues upon binding ketoconazole indicates 
that the active site has not adjusted to fit the shape of ketoconazole entirely and 
therefore ketoconazole may retain considerable mobility in the active site, similar to the 
protein residues. This may preclude forming a multitude of contacts of CYP101 with 
ketoconazole, making a solely enthalpy-driven binding unlikely. A recent crystal 
structure of CYP3A4 with ketoconazole in the active site supports this premise, since 
very few contacts are observed between the protein and ketoconazole ligand in the 
active site, allowing much more freedom of movement for the ligand in the active site as 
well as higher B-factors for the surrounding residues (40). It is possible that this 
additional freedom may allow ketoconazole to adopt different orientations in the active 
site of CYP101 or bind to other sites on the surface of the protein, giving rise to the 
observed conformational heterogeneity. However, in CYP3A4, even though the active 
site is much larger than CYP101 and access to multiple orientations around the heme in 
3A4 is more likely, ketoconazole is not observed to take multiple orientations (41). The 
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CYP101 active site is even smaller and may not allow the ketoconazole to adopt 
multiple orientations. We cannot rule out alternate binding modes for ketoconazole, 
however based on observations of single ligand binding in CYP3A4, this seems unlikely.  
 
To account for the high observed affinity, one can propose that the loss in 
enthalpic interactions is compensated by an increase in the entropic contribution from 
the increased dynamics in the protein and ligand. It is possible that the increased 
entropy may also result from the release of disordered solvent molecules upon binding 
of ligands or may result from desolvation effects. However, our observation that the 
dynamic changes are propagated throughout the protein and not restricted only to the 
binding sites indicates that it is largely a protein-centric event as the protein adjusts its 
mobility differentially in response to the ligand binding. Further desolvation studies for 
the various ligands or osmotic stress experiments to monitor the release of solvent 
molecules however are clearly needed to test this hypothesis and rule out solvent-
based contributions (43-47).  
 
Such increased entropic effects upon binding have been observed previously in 
other protein systems. In a study done by Wand et al on calmodulin, it was observed 
that there was a significant change in the conformational entropy of the amino acids of 
the protein that bound to different target peptides (21). This indicates the possibility that 
in order to accommodate different substrates, parts of CYP101 may change their 
conformational dynamics. It is important to know the identity of these regions and the 
timescales of motions that are affected the most. In this project, we therefore seek to 
elucidate specific residues that undergo a change in their dynamics and their rate of 
dynamic motion using hydrogen-deuterium exchange (HDX) detected by NMR 
spectroscopy. We propose that CYP101 utilizes a dynamic change mechanism as a 
means to effect differential binding of ligands as part of an overall strategy involving 
entropy/enthalpy compensation. HDX experiments will allow us to characterize these 
dynamic changes on a global scale and provide insights into the types of slower 
motions that facilitate the changes observed in the NMR spectra of the various ligand-
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bound forms. Furthermore, these experiments will set the stage for investigation of the 
full spectrum of dynamics on all timescales using CPMG exchange and NMR spin 











































PREPARATION AND CHARACTERIZATION OF CYP101 IN PRESENCE 
OF VARIOUS LIGANDS 
 
Cell Growth and Protein Expression: Competent BL-21 (DE3) E.Coli cells were 
transformed with a plasmid that encodes CYP101 with a fused His6 tag. A single colony 
of BL-21 cells was used to inoculate 50 mL of sterile LB medium containing 50 µL of 
both kanamycin and chloramphenicol antibiotics, each at a stock concentration of 50 
mg/mL. After the cells reached a certain optical density (OD600 ~ 0.6), they were 
transferred to sterile centrifuge tubes and centrifuged for 15 minutes at 6000 RPM and 
4°C. The cell pellet was then resuspended in 1 liter of defined M9 media (M9) consisting 
of the following ingredients: 7.0g sodium phosphate dibasic anhydrous, 3.5g of 
potassium phosphate monobasic and 0.5g of sodium chloride/L, 1mL each of 
kanamycin and chloramphenicol antibiotics, 1g of ammonium chloride (N15 ammonium 
chloride can be used here in order to isotopically label the protein. Unless noted, N14 is 
used), 4g of dextrose, 70µL of 0.5 M iron(III) chloride, 100 µL of 1M calcium chloride, 
1mL of trace metals (contents in g/L: 5 Na2EDTA; 0.5 FeCl3; 0.05 ZnCL2; 0.01 CuCl2; 
0.01 CoCl2.6H2O; 0.01 H3BO3; 1.6 MnCl2.6H2O), 1mL of 1M magnesium sulfate and 25 
µL of 2% thiamine.  
 The cells were grown in the defined media until they reached an optical density 
of 1 as measured at 600 nm, and then induced with 1 mL of 1M isopropyl β-D-
thiogalactopyranoside (IPTG) solution for protein expression. Also, 35mg/L of delta-
amino levulinic acid hydrochloride was added as heme precursor at the time of 
induction. Cells were harvested 4-6 hours after induction via centrifugation at 5000rpm, 
weighed and stored at -80°C until further use. 
 
CYP101 Purification: Frozen cells were thawed and resuspended in 50mL of 
buffer A (2mM camphor, 50mM KPO4, 50mM KCl) per 10g of cells. The resuspended 
solution was then cooled and sonicated for three cycles of 20 seconds each with one 
minute pauses between cycles on a Branson sonifier 250. This is done in order to lyse 
the cells and extract the protein from the cells. The cell lysate was centrifuged for 15 
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minutes at 10,000 RPM and 4°C in a SS-34 rotor, and the supernate was removed from 
the cell debris. The supernate was then run through a Co2+ metal affinity (Talon Metal 
Affinity Resin, Clontech Laboratories) column, which binds CYP101 due to the His6 tag 
present on the protein. The bound protein was then washed with 20 times the column 
volume of buffer A and eluted with buffer A containing 125 mM imidazole solution. The 
eluted protein solution was then passed next through an anion exchange Q Sepharose 
fast flow column (GE Healthcare Life Sciences) and eluted with buffer A containing 250 
mM KCl. The protein was then concentrated using a Millipore 10,000 MW cutoff 
centrifugal filter. Finally, the protein underwent another purification step involving size 
exclusion chromatography on a Amersham FPLC system. Confirmation of purity of 
individual fractions from the size exclusion chromatography was carried out using UV- 
Vis spectroscopy using an absorbance ratio of A391nm/A280nm where this absorbance ratio 
value of >1.4 was deemed to have protein with >95% purity. Concentration of the pure 
protein fractions was determined by following formula (Eq.2): 
A391= εbc       Eq. 2 
A391 represents the absorbance value at 391nm, where the heme absorbs in the 
presence of camphor, ε is the extinction coefficient, which is 100 M−1 cm−1 for CYP101, 
b represents the path length of 1cm of the UV vis cuvette and c is the molar 
concentration of the protein. A characteristic UV-Vis scan (wavelength range 250-
450nm) of the purified CYP101 protein bound to camphor is shown in Figure 10. The 
camphor bound CYP101 protein exhibits two major peaks in the UV vis spectrum in the 
selected wavelength range, The peak at about 280 nm arises from the aromatic 
residues present in the protein, while the 391 nm peak represents the absorbance of the 
heme group in the protein affected by the presence of camphor. This peak will shift 
depending on which ligand, if any, is bound in vicinity of the heme group. 
 
Ligand Exchange: Since CYP101 is purified in buffer containing camphor, all 
purified protein samples are in camphor-bound form. In order to prepare CYP101 in a 




Figure 10: UV Vis absorbance spectrum of purified camphor-bound CYP101. The 













ligand exchange process. ~1mL of concentrated, purified camphor-bound protein was 
diluted with ~15mL of buffer without camphor and re-concentrated back to ~1mL to 
remove substrate via dialysis.This process was repeated 5 times to ensure maximum 
substrate removal, which is indicated by the color change from camphor bound (brown) 
to substrate-free form (red). Then in the final step, camphor-free buffer A containing 
either 2mM of nicotine solution or 2 mM of ketoconazole solution was added to the 
protein to allow for ligand binding. The protein was then re-concentrated to ~0.2 mM, 
and was used further for UV-Vis characterization and NMR studies. 
 
Preparation of samples for NMR spectroscopy: The final NMR samples used for 
amide exchange experiments consisted of 0.2 mM of 15N CYP101 in 50 mM potassium 
phosphate, 50 mM KCl, pH 7.4 buffer. The camphor-bound NMR samples used for 
amide exchange studies additionally contained 2 mM camphor. Ketoconazole and 
nicotine bound NMR samples similarly contained 2 mM ketoconazole and 2 mM nicotine 
respectively for acquisition of 1H-15N correlation spectra. 
 
UV-Vis characterization of substrate-free and ligand-bound forms of CYP101: 
UV-Vis scans of substrate-free, nicotine-bound and ketoconazole-bound forms of 
CYP101 were obtained in a fashion similar to the camphor-bound form described above 
(Figure 11). Binding of the ligand was monitored by small shifts in wavelength of the 
absorbance peak at 391 nm observed in the camphor-bound form. In the substrate-free 
form, this peak shifts to 417 nm due to removal of camphor. Upon binding of the 
nicotine ligand, the wavelength of this peak shifts to approximately 420 nm, indicating 
the characteristic presence of CYP101 bound to an inhibitor. Upon binding of the 
inhibitor ketoconazole, however, the peak does not change its position relative to the 
substrate-free form but just gets broader. This is similar to what has been characterized 
previously in UV-Vis studies with these inhibitors (42). The substrate-free and various 
ligand-bound forms of 15N labeled CYP101 were then prepared in a similar manner and 




15N selective labeling of CYP101 by amino acid type: In order to facilitate further 
sequence-specific assignments for CYP101, protein samples selectively labeled with 
15N at backbone amides for the amino acid types Ala, Gly, Glu, Asp, Leu and Phe were 
prepared in the following manner – Cell growths and CYP101 protein expression were 
carried out exactly as described above except that each15N labeled amino acid was 
added along with 19 unlabeled amino acids in the following amounts (g/L) one hour 
prior to the time of induction: 1.0 S, 0.5 E, 0.4 D, 0.25 A, 0.25 G, 0.25 Q, 0.25 V, 0.25 L, 
0.25 M, 0.25 T, 0.2 I, 0.2 N, 0.15 F, 0.15 Y, 0.15 K, 0.15 H, 0.15 R 0.125 C, 0.1 W, 0.0 
P.   The unlabeled equivalent was excluded for each individual labeled growth. The 
induction procedure was the same as described above. CYP101 expressing cells were 
harvested and the selectively labeled protein purified similar to the unlabeled or15N 
uniformly labeled protein. All samples were prepared in the camphor-bound form. Each 

















Figure 11: UV-Vis characterization of CYP101 in presence of different ligands. 
Characteristic UV-Vis peaks in the spectra for substrate-free CYP101 (red) and bound 
to various ligands [camphor-bound (blue), nicotine-bound (green) and ketoconazole-



























HYDROGEN-DEUTERIUM EXCHANGE NMR STUDIES ON CYP101 
 
4.1 Collection of amide exchange data for CYP101 using NMR spectroscopy 
 
Multiple techniques should be used in order to gain the most complete dynamic 
picture of an enzymatic system, since different processes occur on different timescales.  
The distinct motions at different timescales explain how the dynamics of the protein can 
influence differential binding. Essentially, all dynamic motions are responsible for protein 
dynamics. The fast bond vibrations build in to the slower motions, like a domino effect. 
These slower motions that facilitate differential substrate binding are the focus of this 
study. Hydrogen-deuterium exchange, amide exchange or HDX is a technique used to 
observe slower timescale dynamic motions, from millisecond-second, which provides an 
excellent way to observe larger domain motions and structural changes. The technique 
takes a hydrogenated protein devoid of all water, and replaces the exchangeable 
protons with deuterons by placing it in deuterated water (D2O). The exchange of protons 
with the deuterons occurs in a time dependent manner, according to the accessibility of 
the exchangeable protons. The surface ones will exchange first, while those more 
buried will take a certain amount of time (Figure 12). 
 
This exchange process can be monitored by 2D NMR spectroscopy, and the 
peaks corresponding to each protein residue can be seen to decrease in intensity if they 
are exchanging with the deuterons. There will come a point, when a peak is completely 
exchanged, it will disappear from the spectrum, since deuterium is not a spin half 
nucleus and cannot be detected by traditional NMR methods. Since HDX is a slow 
timescale technique, much information can be gained from this methodology. The rate 
of exchange can be calculated from the peak intensity (Equation 3) which can also give 
















Figure 12: Mechanism of Hydrogen/Deuterium exchange (HDX). Exchangable 
hydrogens of proteins are exposed to D2O, and over time the deuterons will take the 
place of the protons. This process can be detected through NMR and Mass 











                                                    ln I = lnIo-Rext                                         Eqn.    3     
                                    
where I is peak intensity, I0 is the initial intensity, Rex is the exchange rate and t is time 
period of the exchange (44). In addition, often the peak environment can be determined 
from this technique. For example, if the hydrogen being exchanged is a part of a 
hydrogen bond, the chemical shifts will be different than those hydrogens not involved in 
any interactions. The data can be analyzed from that perspective, and used to identify 
the presence of hydrogen bonds.  
 
Amide exchange studies were carried out on CYP101 to compare the exchange 
rates between substrate-free and camphor-bound forms of CYP101 and characterize 
the regions experiencing slower timescale motions in CYP101. In order to carry out the 
exchange studies, CYP101 NMR samples were lyophilized overnight. Then, samples 
were hydrated with D2O and immediately placed in a Varian 600 MHz spectrometer 
equipped with cold probe. Data collection started within the first 5 minutes of the D2O 
addition to allow for detection of fast exchanging resonances. 1H-15N 2D correlation 
spectra were collected with a traditional TROSY pulse sequence at 35° C. Each 
experiment consisted of 8 scans acquired with 1024 complex points in the direct 
dimension and 64 increments in the indirect dimension. The total acquisition time for 
each spectrum was approximately 28 minutes. A series of such spectra for substrate-
free and camphor-bound forms of CYP101 were collected over a period of 39 hrs. The 
spectral acquisition was stopped at this time to prevent spurious data collection since 
CYP101 tends to become unstable and denature at 350 C after approximately 40 hours 
based on prior experience with other NMR experiments on CYP101. The resulting 
spectral data was processed using NMRPipe and SPARKY software (45, 46) to extract 
peak intensities from each dataset. Only simple exponential window functions were 
used during data processing with no baseline corrections. Peak intensities were 
measured only for peaks for which assignments were available and fitted to Equation 3 
as a function of time to obtain amide exchange rates (Rex) for corresponding peaks 
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(Figures 13 and 14). Available amide exchange rates for both substrate-free and 
camphor-bound forms are listed in Table 1.   
 
4.2 Comparison of amide exchange rates between substrate-free and camphor-
bound forms of CYP101 
 
Analysis of amide exchange data for substrate-free and camphor-bound forms 
reveals that only about 40% of resonances remain in the spectrum for each form after 
collection of the first spectrum corresponding to about 33 minutes of exposure to D2O 
(Figure 15). The camphor-bound form retains a few more peaks in the spectrum 
compared to the substrate-free form, but not by much. This indicates that the surface-
exposed residues exchange fast with the solvent in a similar fashion for both forms, 
which is expected from the overall similar structures for both forms of the protein. The 
differences in the exchange preference for a few residues more in the substrate-free 
form may reflect the exposure of more residues to the solvent due to the relatively open 
conformation sampled by the substrate-free form compared to the closed camphor-
bound form.  It is also observed that the camphor bound form has nicely defined peaks 
while the substrate free looks a little bit more disordered due to presence of additional 
line broadening relative to the camphor-bound form (Figure 13). While the faster 
exchange processes are similar for both forms, considerable differences are observed 
for the slower exchanging peaks. Over the various time points of data collection 
following the first time point, the peak intensities for both forms continue to decrease 
steadily in an exponential manner until after approximately 16 hrs, only about 20% of 
the peaks initially observed for camphor-bound form remain protected from the solvent, 
while less than 10% remain for the substrate-free form. These remaining peaks do not 
lose much intensity for the remainder of exchange time in the experiment. On this basis, 
we can classify the exchange process into 3 categories – 1) fast exchange (less than 33 
min), 2) intermediate exchange (33 min to 16 hrs) and 3) slow exchange (16 hrs to 39 
hrs). The differences in exchange rates for the peaks in these 3 categories will be 






Figure 13: Logarithmic plots of peak intensities vs time for two example residues 






Figure 14: Logarithmic Plots of peak intensities vs. time for two example residues 









Table 1: H/D exchange rates measured by NMR for camphor-bound and 
substrate-free CYP101.  Bold secondary structures are indicative of substrate binding 
regions. A (-) indicates no rates were measured for that residue. Error values were 
calculated from the fitting error to the logarithmic plots. 
 
Camphor Bound Substrate Free 
Residue K(s-1) Error K(s-1) Error 
Secondary 
Structure 
12-NH Fast   fast   
18-NH 5.5 x 10-5 3.3 x 10-6 6.9 x 10-5 1.3 x 10-6 turn 1 
24-NH 2.3 x 10-7 0.8 x 10-7 4.3 x 10-6 2.8 x 10-7   
36-NH --   5.5 x 10-6  1.2 x 10-6 turn 3 
37-NH Fast   fast   turn 3 
40-NH 8.7 x 10-6 2.8 x 10-6 fast     
42-NH 1.1 x 10-6 4.6 x 10-7 --   A Helix 
47-NH 2.8 x 10-6 1.1 x 10-6 --   turn 4 
50-NH 3.4 x 10-5 1.4 x 10-6 5.8 x 10-5 3.4 x 10-6 turn 4 
52-NH 4.6 x 10-6 1.7 x 10-6 --     
54-NH 4.6 x 10-6 1.7 x 10-6 6.2 x 10-6 2.4 x 10-6   
55-NH 3.8 x 10-6 1.2 x 10-6 3.4 x 10-6 1.4 x 10-6 β1 
59-NH 4.1 x 10-6 1.6 x 10-6 2 x 10-7 4.5 x 10-6 turn 5 
60-NH Fast   fast   turn 5 
62-NH 2.8 x 10-7 0.7 x 10-7 --     
63-NH --   7.8 x 10-5 2.5 x 10-6 β1 
64-NH 4.3 x 10-6 2.5 x 10-6 5.9 x 10-6 1.6 x 10-6 β1 
65-NH 6.7 x 10-7 2.5 x 10-7 --   β1 
67-NH 5.3 x 10-7 1.2 x 10-7 6.2 x 10-6 2.5 x 10-6 B Helix 
68-NH Fast   fast   B Helix 
70-NH Fast   fast   B Helix 
80-NH 6.4 x 10-7 1.8 x 10-7 5.1 x 10-5 4.5 x 10-6   
81-NH 4.8 x 10-7 1.3 x 10-7 2.5 x 10-6 6.5 x 10-7   
82-NH 5.6 x 10-6 5.5 x 10-7 fast     









Continuation Table 1 
 
Camphor Bound Substrate Free 




87-NH Fast   Fast   B' helix 
88-NH Fast   Fast     
90-NH Fast   Fast     
91-NH Fast   Fast   B' helix 
92-NH Fast   Fast   B' helix 
93-NH Fast   Fast   B' helix 
94-NH Fast   Fast   B' helix 
95-NH Fast   Fast   B' helix 
96-NH Fast   Fast   B' helix 
98-NH Fast   Fast   B' helix 
101-NH Fast   Fast   B' helix 
102-NH Fast   Fast   B' helix 
104-NH Fast   Fast   B' helix 
107-NH Fast   Fast   C helix 
119-NH 3.3 x 10-5 1.8 x 10-6 Fast   C helix 
123-NH Fast   7.7 x 10-5 2.2 x 10-6 C helix 
124-NH Fast   Fast   C Helix 
129-NH Fast   2.3 x 10-7 1.4 x 10-7   
145-NH --   --   β1 
146-NH 6.7 x 10-5 4.9 x 10-6 7.3 x 10-5 3.5 x 10-6 β1 
147-NH --   0.9 x 10-7 5.5 x 10-8 β1 
148-NH 3.2 x 10-7 0.6 x 10-7 1.5 x 10-7 0.5 x 10-7 β1 
149-NH Fast   6.2 x 10-7 1.8 x 10-7 β1 











Continuation Table 1 
  
Camphor Bound Substrate Free 
Residue K(s-1) Error K(s-1) Error 
Secondary 
Structure 
151-NH Fast   fast   E Helix 
152-NH Fast   5.6 x 10-6 2.4 x 10-6 E Helix 
154-NH Fast   fast   E Helix 
161-NH Fast   1.2 x 10-6 5.6 x 10-7   
164-NH Fast   fast     
168-NH 8.9 x 10-5 6.5 x 10-6 8.1 x 10-5 6.5 x 10-6   
169-NH 4.8 x 10-5 5.5 x 10-6 --     
171-NH Fast   fast   turn 8 
172-NH Fast   fast     
185-NH 6.4 x 10-6 2.4 x 10-6 5.2 x 10-6 2.5 x 10-6 F Helix 
186-NH 3.8 x 10-7 1.2 x 10-7 4.6 x 10-6 2.7 x 10-6   
188-NH Fast   fast   FG Loop 
189-NH Fast   fast   FG Loop 
190-NH Fast   fast   FG Loop 
191-NH --   --   FG Loop 
192-NH --   fast   FG Loop 
193-NH Fast   fast   G Helix 
207-NH 4.6 x 10-6 7.7 x 10-7 --   G Helix 
216-NH Fast   fast   H Helix 
217-NH 1.9 x 10-7 0.4 x 10-7 7.8 x 10-7 2.2 x 10-7 H Helix 
226-NH Fast   fast   H Helix 
230-NH Fast   fast   β2 
243-NH 5.6 x 10-5 6.5 x 10-6 fast   I Helix 
245-NH 6.3 x 10-6 2.4 x 10-6 --   I Helix 














Residue K(s-1) Error K(s-1) Error 
Secondary 
Structure 
297-NH --   --   β3 Sheet 
305-NH 2.2 x 10-7 7.6 x 10-8 5.1 x 10-6 1.4 x 10-6   
306-NH fast   fast   β4 
307-NH 4.5 x 10-7 6.5 x 10-8 3.8 x 10-6 7.6 x 10-7 turn 11 
308-NH 1.5 x 10-7 2.2 x 10-8 6.6 x 10-6 2.4 x 10-6 turn 11 
309-NH fast   9.1 x 10-5 1.5 x 10-6 turn 11 
312-NH 1.8 x 10-7 3.8 x 10-8 7.3 x 10-6 2.3 x 10-6 β4 
325-NH fast   fast     
326-NH 3.8 x 10-6 1.6 x 10-6 fast     
329-NH fast   fast   turn 12 
330-NH fast   fast   turn 12 
334-NH fast   fast   turn 13 
338-NH fast   fast     
339-NH --   8.6 x 10-5 7.6 x 10-6   
340-NH fast   fast     
376-NH fast   fast     
384-NH 2 x 10-5 4.2 x 10-6 9.2 x 10-5 6.5 x 10-6 turn 16 
389-NH fast   fast   β5 
390-NH fast   fast   β5 
391-NH fast   6.8 x 10-6 2.2 x 10-6 β5 
392-NH 3.7 x 10-7 1.1 x 10-7 fast   β5 Sheet 
393-NH fast   fast   β5 Sheet 
394-NH 3.3 x 10-7 0.5 x 10-7 --   β5 Sheet 
398-NH 4.4 x 10-7 1.5 x 10-7 fast   β5 Sheet 
400-NH fast   fast     
410-NH fast   fast     













Figure 15: Comparison of HDX NMR data for camphor-bound and Substrate-free 
CYP101. Decrease in peak intensities of camphor bound and substrate free HDX 
CYP101 in 2D 1H-15N HSQC-TROSY NMR spectra collected at 35°C is shown over a 
period of time marked over each spectrum. The first panel shows a non-HDX TROSY 
NMR spectrum for 15N CYP101 in the same conditions as the HDX spectra and was 















4.3 Additional assignments from 15N selective labeling of CYP101  
 
CYP101 has a total of 414 amino acids in its sequence, however assignments 
are available only for 107 residues in the oxidized form of the protein. Considerably 
more number of assignments are available for the reduced form of the protein (~290 
residues). There are several reasons for this. The main reason is that oxidized CYP101 
with its Fe+3 oxidation state of the heme iron is paramagnetic around room temperature, 
while reduced CYP101 with Fe+2 oxidation state of the heme iron is diamagnetic. This 
entails paramagnetic broadening of resonances up to a distance of 8 Å from the heme 
center in the oxidized form, which causes loss of resonances in the oxidized CYP101 
TROSY spectrum and makes assignment of resonances even more difficult due to loss 
of sequential connectivities. 
 
The traditional experiments used for protein backbone assignments are the 
three-dimensional multinuclear experiments such as HNCA, HNCO and HNCACB. 
These experiments rely on proteins that have been isotopically labeled with 15N, 13C and 
2H for detection. HNCO allows direct correlation of the N-H chemical shifts with the 
backbone carbonyl C=O chemical shifts of the previous residue. HNCA experiments not 
only detect the transfer of magnetization from the N-H bond of the residue of interest (i), 
to its own Cα,(i), but also the Cα of the previous residue (i-1). This allows sequential 
connectivity to be built between the residues, and allows walk-through of assignments 
through the protein sequence. However, HNCA and HNCO experiments by themselves 
are insufficient to provide unambiguous sequential assignments. HNCACB is also used 
to resolve ambiguities and obtain a more complete set of assignments, including partial 
side-chain assignments. This experiment correlates the Cα and Cβ chemical shifts of 
residues i and i-1, with the N-H (i) chemical shift.  Subsequently, the chemical shift 
analysis of the residues allows them to be matched up and the connectivities formed 
between various residues. The chemical shifts between oxidized and reduced forms are 
distinct enough to prevent direct transfer of most assignments from reduced to oxidized 
CYP101. In addition, oxidized CYP101 resonances tend to be generally broader than 
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the reduced form and thus magnetization transfer does not occur very efficiently in 3D 
NMR experiments used for assignment. Thus, traditional 3D NMR experiments have 
been less effective in obtaining assignments for more than 107 in oxidized CYP101. 
During the assignment process using 3D NMR experiments such as HNCA and 
HNCACB, there are several small stretches of sequential connectivities observed in 
oxidized CYP101, but definite assignments cannot be made due to ambiguity.  A way to 
overcome some of this ambiguity will be to identify the amino acids forming sequential 
connectivities by amino acid type and hope to find unique pairs in the amino acid 
sequence connecting two of the amino acid types, which will allow us to place them 
sequence-specifically in combination with other sequential connectivities and thus 
assign them. Selective labeling of amino acids within the protein is a simple way to 
accomplish the marking of resonances by amino acid type and therefore selective 
labeling of several amino acid types was undertaken in CYP101. 
     
 NMR samples of CYP101 selectively labeled with 15N at the backbone amides 
were prepared for the following amino acid types – Ala, Gly, Leu, Phe, Asp and Glu 
using methods described in Chapter 3. The specific amino acid types were selected as 
a preliminary set for labeling based on the following criteria - their higher prevalence in 
the amino acid sequence of CYP101, their likely involvement in stretches of sequential 
connectivities in 3D experiments, easy identification due to their somewhat unique 
chemical shifts and their propensity to scramble the 15N label to other amino acids (47). 
1H-15N TROSY spectra for these selectively labeled samples were collected and 
matched up with a uniformly labeled spectrum to identify assigned and unassigned 
peaks in the uniformly labeled spectrum by amino acid type (Figures 16 and 17). The 
unassigned peaks now identified by amino acid type are now being reassessed in the 
3D NMR data in the hopes that additional assignments can be made available for these 





Figure 16: NMR spectra of CYP101 selectively labeled with 15N Alanine and 
Glycine. Portions of NMR spectra of selectively labeled (burgundy for alanine, teal for 
glycine) and uniformly labeled (black) CYP101 are shown for comparison. Boxes in red 




Figure 17: NMR spectra of CYP101 selectively labeled with 15N Phenylalanine and 
Leucine. Portions of NMR spectra of selectively labeled (magenta for leuine, gold for 
phenylalanine) and uniformly labeled (black) CYP101 are shown for comparison. Boxes 








The selective labeling of the preliminary set of amino acids was reasonably 
successful. For amino acids such as Phe and Ala, there was very minor scrambling of 
the 15N label to other amino acids and thus the expected number of resonances 
(excluding the ones not observed due to paramagnetic broadening) were observed for 
these amino acids. Minor scrambling was observed for the Gly label to other amino 
acids such as Ser and Cys. On the other hand, major scrambling was noticed in the 
spectra for the Leu and Glu labels. Due to the inter-conversion of these amino acids 
with other amino acids as part of the metabolic pathways, some of the labeled nitrogens 
were incorporated in other amino acids, such as Ile and Val for Leu, while Glu 
scrambled to Gln and other unknown amino acids. The Asp labeled protein did not 
express in sufficient quantity to obtain a good quality NMR spectrum and ascertain its 
scrambling. Although scrambling posed a problem for unambiguous identification of 
amino acid type for several of the resonances in Leu and Glu selectively labeled 
samples as the number of peaks in the spectra did not correspond to the number of 
amino acids in the sequence, the peak intensities of the original label were generally 
higher and helped identify most of the possible peaks for that amino acid type.  
 
The use of this methodology of using the higher intensity peaks for amino acid 
type identification is however not foolproof and the identities of these peaks need to be 
confirmed in subsequent analysis of 3D NMR data. However, the good matching of 
some of the higher intensity peaks with the previously assigned resonances of that 
amino acid type lends credence to this method and these peaks may serve as a good 
starting point for further 3D data analysis.  Additional selective labeling of other amino 
acids will be conducted in future if these labels are unable to resolve ambiguities and 
provide more assignments for oxidized CYP101. 
 





Local dynamics in CYP101 were monitored using amide proton exchange rates 
for both substrate-free and camphor-bound forms. Overall, the H/D exchange in the 
substrate-free form was much faster than the camphor-bound form, almost by an order 
of magnitude in the majority of residues that could be analyzed. Significant differences 
are observed at the beginning of the B’ helix, portions of the C helix as well as the I helix 
and the β5 sheet (Figures 18 and 19).  
 
The B’ helix and β5 sheet form part of the SRS, while the I helix is a key region in 
the active site. A large difference in exchange rates was seen for residue 243, which is 
on the N-terminal side of the I helix “kink”, a region that is distorted and is known to 
change its conformation to provide a binding pocket for oxygen molecule in the reduced 
form. Residue 243 is still visible in the first few camphor-bound spectra acquired after 
D2O addition, however is exchanged out completely even in the first acquired substrate-
free spectrum. We have not been able to monitor exchange rates for other residues in 
the I helix as most of this helix is close to the paramagnetic heme center and its 
resonances are likely broadened out in oxidized CYP101 spectra. However, given the 
fact that this particular helix is known to respond to binding of substrates in almost all 
P450 structures by changing its conformation using the I helix “kink” to fill up the active 
site with the side-chains of several residues depending on the size and type of 
substrate, it is not surprising that we see a larger change in dynamics for this region 
between the substrate-free and camphor bound forms. It is likely that in the substrate-
free form, the solvent has better access to portions of the helix, both due to lack of 
substrate and also due to increased dynamics of the substrate-free form. Our results 
indicate that the active site region may be in general more dynamic in the substrate-free 
form. 
 
Another significant region that shows differential exchange rates in CYP101 is 
the loop between the B and B’ helix, where residues 80-85 show considerably faster 
exchange rates in the substrate-free form compared to the camphor-bound form. This 






Figure 18: Exchange rates for various residues in camphor-bound CYP101 
mapped onto the structure of CYP101. Residues with fast exchange rates (< 33 min) 
are shown in red, and intermediate and slow exchange rates (> 33 min) in yellow. 







Figure 19: Exchange rates for various residues in substrate-free CYP101 mapped 
onto the structure of CYP101. Residues with fast exchange rates (< 33 min) are 
shown in red, and intermediate and slow exchange rates (> 33 min) in yellow. Residues 





and undergoes a large conformational change between the substrate-free and 
camphor-bound forms as evidenced from the crystal structures. The B’ helix is largely 
disordered in the substrate-free form and is likely sampling multiple conformations, 
which upon camphor binding becomes ordered due to formation of H-bond between 
Tyr96 side-chain and camphor. The B’ helix exhibits fast exchange in both camphor-
bound and substrate-free forms, most likely due to its surface location on CYP101, so it 
is not possible to figure out whether there are significant differences in the exchange 
rates for this helix in our experiments. However, the region leading upto the B’ helix 
(residues 80-85) is more protected from the solvent and thus made it possible to 
measure the exchange rates in both forms. The much faster exchange rates in the 
substrate-free form for this region strongly suggests the more dynamic nature of this 
region and by inference also of the B’ helix. 
 
Exchange rates for the β5 sheet, which is also part of the SRS, similarly are 
different in the substrate-free and camphor-bound forms. The β5 sheet region is part of 
the conformational change that leads to the closed conformation from the open 
conformation upon binding of camphor, trapping the substrate inside the active site. 
Residues 392, 394 and 398 are part of the short β-turn that connects the two strands of 
the β5 sheet exchange very slowly in the camphor-bound form and increase their 
exchange rates by almost two orders of magnitude in the substrate-free form. This 
region makes several H-bonding, van der Waals and electrostatic contacts to both the 
C-terminal side of the I helix as well as the N-terminal region in the camphor-bound 
form. Both the N-terminal region of CYP101 and I helix are known to be fairly flexible 
regions. It is therefore possible that movement of the I helix region is coordinated with 
the movement of the β5 sheet to effect binding of camphor. In the substrate-free form, 
since there is no camphor present, the I helix is more dynamic as evidenced by the 
faster exchange rates for residue 243 and this motion disrupts some of its contacts with 
the β5 sheet, leading to the increased dynamics observed for β5 sheet in the substrate-
free form as part of the open conformation. Increased B-factors have been observed for 
most regions in the SRS of substrate-free form (19), including the B’ helix and β5 sheet 
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supporting the observation of increased dynamics in these regions in our experiments 
as well.     
 
Other regions that show increased exchange rates in substrate-free form include 
residues in the C helix region and the β4 turn. The C helix is part of the proximal binding 
site for Pdx and mediates changes from the proximal binding site to the distal binding 
site. It is known from previous NMR studies with the Pdx-CYP101 complex that binding 
of Pdx on the proximal site causes large chemical shift perturbations and dynamic 
changes on the distal site, especially in the SRS regions. It was postulated that Pdx 
serves as an effector by changing the subset of conformations of the substrate access 
channel to prevent loss of substrate to unproductive monooxygenation. The involvement 
of C helix in this mechanism is critical as it likely transmits any dynamic changes to the 
distal site by using the modulation of its own dynamics. Thus it is sensitive to any 
substrate-related dynamic changes and is therefore not surprising that it shows a 
significant dynamic difference between the substrate-free and camphor-bound forms of 
CYP101. The β4 turn region acts like a hinge that connects parts of the proximal site 
region, namely the Cys binding loop and L helix. Thus, dynamic changes in the β4 turn 
residues are likely to mirror other regions in the proximal site.  
 
There are also some local regions that follow a reverse trend of the camphor-
bound form exchanging faster than the substrate-free form. For example, residues in 
the β1 sheet (148-150) and E helix (152 and 161) show much faster exchange rates in 
the camphor-bound form than the substrate form. Increases in exchange rates upon 
binding of camphor are also seen for residues 54 and 59 in the β1 turn region. However, 
the increase in exchange rates are not as high in magnitude compared to the normal 
trend of faster exchange rates in substrate-free form. It is not clear what the purpose of 
these increased exchange rates in the camphor-bound form is, other than they may just 
represent localized increase in fluctuations as a response to picking up the “slack” for 




It is interesting to note that the regions showing the faster exchange rates in the 
substrate-free form versus the camphor-bound forms are similar to the regions showing 
the largest redox-dependent dynamic differences in oxidized versus reduced CYP101 
(44). Parts of the B-B’ helix loop show a decrease in dynamics upon reduction, just as it 
shows a decease in dynamics upon substrate binding. Regions including the β5 sheet 
also show similar trends between both forms. This raises the possibility that there are 
canonical regions in CYP101 that have inbuilt dynamic change capability. This may 
allow these regions to sample multiple conformations and allow selection of different 
subsets of conformation as a function of oxidation state and ligand binding. This notion 
can be tested via design of mutants targeting these regions, which would affect both 
binding and redox-dependent effects that can be monitored via NMR spectroscopy 






















CONCLUSIONS AND FUTURE DIRECTIONS 
 
The dynamics of a protein, particularly an enzyme, are an important determinant 
in its functionality. An enzyme uses its dynamic character, often as a means to facilitate 
promiscuity in binding substrates and control catalysis rates. A likely mechanism by 
which this promiscuity is accomplished is that of conformational selection or equilibrium 
dynamics. Cytochrome P450s are widely believed to employ this mechanism, where 
they use their conformational flexibility to modulate protein-substrate interactions to 
accommodate substrates of differing physic-chemical properties and product specificity. 
An in-depth study of conformational dynamics of P450s is therefore critical to fully 
understand the basis of substrate promiscuity in these enzymes, which will allow better 
design of drugs targeted against them in humans. In this work, the millisecond-second 
dynamic changes that occur upon binding of a substrate to a cytochrome P450 have 
been described. The model system of cytochrome P450cam or CYP101 was chosen for 
this purpose, as preliminary NMR studies showed that it exhibits differential dynamics 
throughout the protein upon binding of distinct ligands.  
 
Hydrogen/deuterium exchange studies using NMR spectroscopy were carried out 
on CYP101 in presence and absence of a substrate to provide a residue-level picture of 
slow dynamic changes taking place in this protein upon binding of a substrate. Although 
previous NMR studies involving H/D exchange have looked at redox-dependent 
changes in CYP101 dynamics, this is the first study that looks at the effect of substrate 
binding on the slow timescale dynamics of this protein. Overall, it is found from this 
study that the substrate-free form of CYP101 exhibits more rapid amide proton 
exchange than the corresponding residues in camphor-bound form of CYP101. Specific 
residues in the substrate recognition sites and active site are found in particular to 
exhibit large differences in exchange rates between the two forms, pointing to the high 
conformational plasticity available to these regions in this protein. The dynamics of 
regions such as the β5 sheet and B’ helix that are part of the substrate recognition sites 





Figure 20:  Comparison of exchange rates for selected regions in camphor-bound 
and substrate-free CYP101. Regions showing the largest differences between the two 
















millisecond timescale of several residues in this region suggest that they may be not 
only part of a gating mechanism allowing access to the active site, but also play an 
important role in the protein adapting to the differing requirements of substrate binding 
specificity. 
 
It would be interesting to follow up on the studies here on the slower timescales 
with ones looking at motions on faster timescales in CYP101. Again, NMR spectroscopy 
is going to be a valuable technique in this regard due to its ability to characterize us-ms 
motions using CPMG relaxation dispersion experiments and on the ps-ns timescale 
using T1/T2 relaxation rate measurements. If similar regions are involved in modulating 
dynamic changes on the faster timescales, that would provide a mechanistic pathway 
for the origin of the slower motions and explain the high conformational plasticity of 
these regions. Such studies on the faster timescales are currently being undertaken for 
CYP101 in complex with various ligands. Our preliminary NMR studies with ligands 
such as nicotine and ketoconazole indicated even more dramatic dynamic differences in 
the proteins than observed in the presence of camphor. An entropy-enthalpy 
compensation mechanism was proposed to account for these dynamic differences as a 
function of ligand binding. This hypothesis certainly needs to be tested further with 
detailed thermodynamic and NMR studies on complexes of CYP101 with these ligands. 
 
Neutron scattering is yet another technique that can be used to gain dynamic 
information on proteins on faster timescales. Neutron beams scattering off from proteins 
can undergo change in momentum and energy of the scattered neutrons relative to the 
incident neutrons leading to elastic or inelastic scattering. Traditionally, this technique 
has been used to study the properties of materials and the behavior of solutes in water 
(48).  Neutron scattering, unlike neutron diffraction, does not gather information at 
atomic level resolution, but on a much larger scale and this information can be utilized 
for larger scale observations, such as global dynamic motions of a protein using 
inelastic or quasielastic measurements. Such measurements are typically carried out on 
hydrogenated proteins that are hydrated powders and can be used to track overall 
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mean-square displacements in the protein as a function of temperature, giving an 
overall picture of the internal dynamics of the protein. One can interpret this global 
picture in terms of individual local-level atomic motions by interpreting the scattering 
parameters in conjunction with molecular dynamics simulations, giving a comprehensive 
picture of the types of motions happening within a protein as it transitions through 
various conformational changes as part of its flexibility. Such methods have been 
applied previously to study global motions in CYP101 (49).  Quasielastic neutron 
scattering was used to compare the global dynamics of substrate-free and camphor-
bound forms of CYP101, where it was determined that substrate-free CYP101 exhibited 
larger amplitude motions than the camphor bound form, although their relaxation times 
were similar. Analysis of relevant MD trajectories identified similar regions exhibiting 
dynamic differences between substrate-free and camphor-bound forms and also on 
much faster timescales. However, the studies could not confirm the presence of any 
correlated motions between these regions. 
 
The information about correlated motions can be garnered via another property 
of neutrons that involves coherent scattering, which occurs when the neutrons within the 
beam are in phase with one another and contribute to the signal, unlike incoherent 
scattering that is used to determine atomic level motions as a result of dephasing of 
neutrons due to their spin. Coherent dynamic neutron scattering, which arises from 
time-correlations in interatomic positions, can be used to derive detailed information on 
large scale collective motions. We have recently performed preliminary coherent 
neutron scattering experiments on CYP101 (50) that reveal the presence of in-phase 
collective dynamic modes running through the entire protein molecule on the ps-ns 
timescale and have found that these collective modes may be involved in the 
conformational gating mechanism in CYP101 to allow substrate access by involving 
similar regions in the substrate recognition sites as identified in this study. Since these 
studies were performed in the camphor-bound form, it will be intriguing to see whether 
the collective modes are also present in the substrate-free form and if so, whether the 
timescales are similar or different to that of the camphor-bound form. Such studies are 
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planned to be undertaken in the future and if successful have the potential to provide 
great insight into the mechanistic basis of the origin of conformational dynamics in 
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